The Senate health committee has announced a series of hearings addressing how healthcare systems can reduce costs in America.

Individuals from Mississippi were indicted for defrauding insurance companies for $200 million with high-priced compounded formulations and bribing providers—including dentists, physicians and nurse practitioners—to prescribe those medications to patients they never examined.

Most American nurses put their patients’ health and safety above their own, potentially impacting patient care, one Pennsylvania nurse wrote in the Journal of Radiology Nursing this month.

Authors of a June 26 editorial in Annals of Internal Medicine advocated for a standard definition of "overdiagnosis" regarding cancer screenings, arguing poor understanding of the term is a threat that exposes patients to unnecessary treatments.

Women with dense breasts see higher cancer rates than their non-dense breast counterparts, suggesting additional screening might be beneficial, a nationwide study out of Norway has found.

A new study found ultra-high strength MRI may release toxic mercury from silver fillings, though commonly used 1.5 Tesla MRI machines appear to have no effect on the cavity-prone.

Prices continue to climb on the Affordable Care Act exchanges, with some estimates calling for 30 percent increases to typical silver-level plans in 2019. But despite the additional challenges faced by individuals on the marketplaces, insurers see clear skies ahead.

18F-Fluciclovine PET/CT can help detect previously undetected lesions in patients with biochemical recurrence of prostate cancer, according to a report presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting.